223 related articles for article (PubMed ID: 3310631)
1. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
Caldwell JR; Roth SH; Wu WC; Semble EL; Castell DO; Heller MD; Marsh WH
Am J Med; 1987 Sep; 83(3B):74-82. PubMed ID: 3310631
[TBL] [Abstract][Full Text] [Related]
2. Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa?
Gudjónsson H; Oddsson E; Thjodleifsson B
Digestion; 1994; 55(6):395-8. PubMed ID: 7705552
[TBL] [Abstract][Full Text] [Related]
3. Sucralfate therapy in NSAID bleeding gastropathy.
Malagelada JR; Rodríguez de la Serna A; Dammann HG; Pons M; Armas C; Sala M; Tena X; Celdrán E; Mesa A
Clin Gastroenterol Hepatol; 2003 Jan; 1(1):51-6. PubMed ID: 15017517
[TBL] [Abstract][Full Text] [Related]
4. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
Miller K
Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
[TBL] [Abstract][Full Text] [Related]
5. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
6. Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs. A pilot study.
Shepherd HA; Fine D; Hillier K; Jewell R; Cox N
Am J Med; 1989 Jun; 86(6A):49-54. PubMed ID: 2735335
[TBL] [Abstract][Full Text] [Related]
7. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
8. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.
Agrawal NM; Roth S; Graham DY; White RH; Germain B; Brown JA; Stromatt SC
Ann Intern Med; 1991 Aug; 115(3):195-200. PubMed ID: 1905501
[TBL] [Abstract][Full Text] [Related]
10. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs.
Swift GL; Heneghan M; Williams GT; Williams BD; O'Sullivan MM; Rhodes J
Digestion; 1989; 44(2):86-94. PubMed ID: 2693162
[TBL] [Abstract][Full Text] [Related]
11. Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.
Hudson N; Murray FE; Cole AT; Filipowicz B; Hawkey CJ
Gut; 1997 Jul; 41(1):19-23. PubMed ID: 9274466
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
13. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
Aabakken L; Larsen S; Osnes M
Scand J Rheumatol; 1989; 18(6):361-8. PubMed ID: 2515593
[TBL] [Abstract][Full Text] [Related]
14. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion in humans.
Stern AI; Ward F; Sievert W
Am J Med; 1989 Jun; 86(6A):66-9. PubMed ID: 2660559
[TBL] [Abstract][Full Text] [Related]
15. The effect of nonsteroidal antiinflammatory drugs on upper gastrointestinal tract symptoms and mucosal integrity.
Katzka DA; Sunshine AG; Cohen S
J Clin Gastroenterol; 1987 Apr; 9(2):142-8. PubMed ID: 3553307
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
Stiel D; Ellard KT; Hills LJ; Brooks PM
Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
Agrawal NM; Dajani EZ
Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
[TBL] [Abstract][Full Text] [Related]
18. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
[TBL] [Abstract][Full Text] [Related]
19. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.
Silverstein FE; Graham DY; Senior JR; Davies HW; Struthers BJ; Bittman RM; Geis GS
Ann Intern Med; 1995 Aug; 123(4):241-9. PubMed ID: 7611589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
